Track topics on Twitter Track topics that are important to you
Refractive Error And Biometry In Retinopathy Of Prematurity PubMed articles on BioPortfolio. Our PubMed references draw on over 21 million records from the medical literature. Here you can see the latest Refractive Error And Biometry In Retinopathy Of Prematurity articles that have been published worldwide.
We have published hundreds of Refractive Error And Biometry In Retinopathy Of Prematurity news stories on BioPortfolio along with dozens of Refractive Error And Biometry In Retinopathy Of Prematurity Clinical Trials and PubMed Articles about Refractive Error And Biometry In Retinopathy Of Prematurity for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Refractive Error And Biometry In Retinopathy Of Prematurity Companies in our database. You can also find out about relevant Refractive Error And Biometry In Retinopathy Of Prematurity Drugs and Medications on this site too.
To evaluate the relationship between zone of retinal vascularization and refractive error in premature infants without retinopathy of prematurity (ROP) or with spontaneously regressed ROP.
We aimed to externally validate the performance of new screening criteria for retinopathy of prematurity (ROP) developed in the Postnatal Growth and Retinopathy of Prematurity (G-ROP) study among a Japanese cohort.
Uncorrected refractive error is the leading cause of visual impairment; therefore, reducing its prevalence is important worldwide. For two decades, there has not been a comprehensive assessment of refractive error in Latin America.
This is a retrospective study of the efficacy of treatment of neonates (NN) with exocryocoagulation retinopathy of prematurity (ROP) with respect to morphology of the retina and visual function.
to describe the influence of oxygen in retinopathy of prematurity (ROP) in premature newborns (PTNB) hospitalized in neonatal units of intensive care and undergoing ophthalmological follow-up procedures after hospital discharge.
To determine the association of refractive error (RE) and its associated determinants (axial length [AL], anterior chamber depth (ACD) and corneal curvature [CC]) with the incidence and progression of diabetic retinopathy (DR).
To identify achieved oxygen saturations (SpO) associated with increased risk of severe retinopathy of prematurity (ROP).
The purpose of this study was to prospectively investigate the association between retinopathy of prematurity (ROP) and ocular growth in premature infants during the earliest weeks of life.
The association between small for gestational age (SGA) and retinopathy of prematurity (ROP) is unclear.
To evaluate the validity of remote telemedicine screening for retinopathy of prematurity (ROP) in a population of at-risk preterm infants in Iowa and South Dakota.
To classify the risk factors that contribute to the development versus progression of retinopathy of prematurity (ROP).
To evaluate the efficacy of a single injection of 0.3 mg of intravitreal ranibizumab for the treatment of retinopathy of prematurity.
To examine the relationship between post-natal growth and development of retinopathy of prematurity (ROP) among preterm infants in southwestern Ontario.
To compare the characteristics of infants whose retinopathy of prematurity (ROP) resolves in 50 weeks' postmenstrual age (PMA) in order to identify which infants are at risk for delayed resolution and to evaluate whether severe ROP developed after 50 weeks' PMA.
Laser/photocoagulation criteria for retinopathy of prematurity (ROP) are generally universal, with > 90% anatomic success reported in varied settings. Outcomes in the Philippines, a developing/lower-middle income nation, were examined.
The Surfactant, Positive Pressure, and Pulse Oximetry Randomized Trial (SUPPORT) demonstrated that static low oxygen saturation decreased retinopathy of prematurity (ROP) but increased mortality compared with static high oxygen saturation cohorts.
To compare large spot versus standard spot laser for treatment of retinopathy of prematurity (ROP).
We present a case series describing a unique entity as it relates to plateau iris. There have been many established risk factors for plateau iris, but we present the following cases which describe patients with plateau iris in the setting of prematurity and/or retinopathy of prematurity (ROP) as well as high myopia or emmetropia. We believe this to be a distinct form of plateau iris resulting from abnormal ciliary body and angle development in the preterm infant. Subjects were treated according to standard ...
Retinopathy of prematurity (ROP) can cause severe visual disability even in high-resource settings. A better understanding of the prevalence and processes leading to ROP-induced severe visual impairment may help health care professionals design preventive measures.
To explore the natural evolution of isolated neovascular tufts ("popcorn") in retinopathy of prematurity (ROP) and its significance in the progression of acute ROP.
To report the occurrence of lens injury during intravitreal anti-vascular endothelial growth factor (anti-VEGF) injection in infants with retinopathy of prematurity (ROP).
To investigate white matter maturation in preterm infants with and without retinopathy of prematurity (ROP) and to determine whether ROP is associated with white matter microstructural integrity at term-equivalent ages.
This study assessed the efficacy and safety of early vitamin A (VA) supplementation to improve outcomes of retinopathy of prematurity in extremely preterm infants.
To compare the time course of retinopathy of prematurity (ROP) in premature (≥ 28 to 34 weeks' gestational age) and extremely premature (< 28 weeks' gestational age) infants.
To describe the incidence of retinopathy of prematurity (ROP) in the Christchurch Hospital neonatal intensive care unit over a 10-year period.